Abstract:
The present invention relates to a composition comprising a Synurus deltoides (Aiton) Nakai extract for inhibiting cell aging. The composition, comprising the Synurus deltoides (Aiton) Nakai extract having an excellent effect of inhibiting cell aging as an active ingredient, can be used for preventing age-related diseases, such as skin aging, rheumatoid arthritis, osteoarthritis, hepatitis, chronic damage to skin tissues, arteriosclerosis, prostatic hyperplasia, or liver cancer.
Abstract:
본 발명은 뇌기능 및 인지 기능 개선 활성을 갖는 조성물에 관한 것으로서, 보다 상세하게는 노루궁뎅이버섯, 노랑느타리버섯 및 세송이버섯으로 구성된 군에서 선택된 2종 이상의 버섯의 물 추출물을 유효성분으로 함유하는 뇌기능 및 인지 기능 개선용 조성물에 관한 것이다.
Abstract:
The present invention relates to a composition for improving brain function and cognitive function. In particular, the composition for improving brain function and cognitive function contains two or more mushroom extracts, selected from a group consisting of Hericium erinaceum, Pleurotus cornucopiae, and Pleurotus eryngii, as active ingredients.
Abstract:
The present invention relates to a composition for preventing and treating obesity and lipid-related metabolic diseases and a method for manufacturing the same. The composition of the present invention comprising powdered herbal components can suppress differentiation of adipocytes and generation of triglycerides, has excellent functionality, and has an effect of inhibiting obesity such as weight loss and blood lipid level reduction in obesity-induced animals by inhibiting differentiation of adipocytes, thereby being greatly helpful for preventing and treating obesity and lipid-related metabolic diseases.
Abstract:
The present invention relates to a pharmaceutical composition and a health functional food containing an extract of Abutilon theophrasti Medicus leaf as an active component and, more specifically, to a pharmaceutical composition for preventing and treating an inflammatory disease characterized by an extract of Abutilon theophrasti Medicus leaf inhibiting the expression of an inflammatory protein in the body comprising one or more element among a group composed of cyclooxygenase-2 (COX-2), nitric oxide synthase (iNOS), and nuclear factor kappa B (NF-kB). The pharmaceutical composition and health functional food has anti-inflammation, anti-oxidation, and anti- arteriosclerosis activities.
Abstract translation:本发明涉及药物组合物和含有作为活性成分的芸香属植物提取物的保健功能性食品,更具体地,涉及用于预防和治疗以Abutilon theophrasti Medicus leaf的提取物为特征的炎性疾病的药物组合物 包括由环氧合酶-2(COX-2),一氧化氮合酶(iNOS)和核因子κB(NF-kB)组成的组中的一种或多种元素的体内炎性蛋白的表达。 药物组合物和保健功能食品具有抗炎,抗氧化和抗动脉硬化的作用。
Abstract:
PURPOSE: A composition containing a Lithospermum erythrorhizon Sieb. et Zucc. root extract is provided to significantly treat osteoarthritis and to be used as an agent for preventing and treating osteoarthritis or as a health food for treating osteoarthritis. CONSTITUTION: A therapeutic agent for treating osteoarthritis contains effective amount of natural pigments of Lithospermum erythrorhizon Sieb. et Zucc. roots. The natural pigment is a shikonin derivative, acetyl shikonin. An agent for preventing osteoarthritis contains effective amount of the natural pigments. A method for preparing a Lithospermum erythrorhizon Sieb. et Zucc. root extract for preventing and treating osteoarthritis comprises the steps of extracting Lithospermum erythrorhizon Sieb. et Zucc. roots with a non-polar solvent and obtaining the natural pigments. A method for preparing a Lithospermum erythrorhizon Sieb. et Zucc. root extract for preventing and treating osteoarthritis comprises the step of extracting the natural pigments by supercritical extraction. [Reference numerals] (G2) MIA + green-shelled mussel oil extract 150mg/kg; (G3) MIA + supercritical extract of Lithospermum erythrorhizon Sieb. et Zucc. 200mg/kg; (G4) MIA + acetylshikonin of Lithospermum erythrorhizon Sieb. et Zucc. 5mg/kg